HAE — HAEMONETICS CORP
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 313143 ·
Last close
$119.47
Market Cap
$5.44B
52W High
$120.72
52W Low
$48.17
ADV30
646,605
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 339,380,000 | 202,803,000 | 57,458,000 | 33,010,000 | 2,365,400,000 | 223,384,000 | 1,528,299,000 |
| Mar 2026 | 346,351,000 | 198,212,000 | 52,342,000 | -20,147,000 | 2,395,925,000 | 245,440,000 | 1,599,605,000 |
| Dec 2025 | 338,967,000 | 202,386,000 | 68,112,000 | 44,740,000 | 2,490,890,000 | 363,367,000 | 1,579,439,000 |
| Sep 2025 | 327,315,000 | 194,744,000 | 67,075,000 | 38,684,000 | 2,442,156,000 | 296,426,000 | 1,592,983,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$328,149,000
Investing CF
$-168,781,000
Financing CF
$-227,546,000
CapEx
$-36,932,000
Dividends Paid
—
Buybacks
$-250,000,000
EPS Diluted TTM
$2.04
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$311,516,000
Inventory
$306,739,000
Receivables
$216,071,000
ST Investments
—
EBIT TTM
$160,320,000
Pretax Income TTM
$130,435,000
Interest Exp TTM
$29,885,000
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,352,013,056
EBITDA
$358,785,984
Free Cash Flow
$312,840,000
Enterprise Value
$5,621,733,376
Total Cash
$224,516,992
Total Debt
$1,174,157,952
Shares Out
45,497,051
Trailing EPS
$2.07
Book Value
$18.41
ROE
11.2%
ROA
6.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,334,027,000 | 241,401,000 | 97,308,000 | 2,395,925,000 | 1,599,605,000 | 796,320,000 | 293,221,000 |
| Mar 2025 | 1,360,824,000 | 201,186,000 | 167,679,000 | 2,450,948,000 | 1,630,112,000 | 820,836,000 | 181,725,000 |
| Mar 2024 | 1,309,055,000 | 175,302,000 | 117,558,000 | 2,195,591,000 | 1,235,632,000 | 959,959,000 | 181,751,000 |
| Mar 2023 | 1,168,660,000 | 155,651,000 | 115,401,000 | 1,934,825,000 | 1,116,828,000 | 817,997,000 | 273,058,000 |
TTM Snapshot
Revenues TTM
$1,318,275,000
NetIncome TTM
$175,436,000
OpCashFlow TTM
—
Assets (Latest)
$2,490,890,000
Forward EPS
$5.74
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MMED | MiniMed Group, Inc. | $5.57B | $19.80 | — |
| TFX | TELEFLEX INC | $5.26B | $124.19 | — |
| MMSI | MERIT MEDICAL SYSTEMS INC | $5.09B | $85.25 | — |
| ITGR | Integer Holdings Corp | $4.31B | $126.65 | — |
| MSA | MSA Safety Inc | $6.87B | $178.10 | — |
News headlines (Yahoo Finance, 1h cache)
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?
2026-10-09 10:43 · Yahoo
Haemonetics (HAE) Jumped, What Is Behind The Move?
2026-10-09 05:09 · Yahoo
HAE, PCRX Stocks Hit Multi-Year Highs Amid Broader Market Selloff – What’s Driving The Momentum Today?
2026-10-08 17:48 · Yahoo
Haemonetics shares jump as CSL sets 2027 rollout of plasma devices
2026-10-08 15:18 · Yahoo
Haemonetics Soars 12% on CSL Update: Plasma Giant to Roll Out NexSys Across U.S. Centers
2026-10-08 14:30 · Yahoo
Haemonetics Stock Surges as Plasma Deal Opens Door to More Revenue
2026-10-08 14:09 · Yahoo
Haemonetics stock surges 17% on CSL Plasma supply deal update
2026-10-08 13:13 · Yahoo
PAHC vs. HAE: Which Stock Is the Better Value Option?
2026-10-05 14:40 · Yahoo
Haemonetics (HAE) Could Be 66% Undervalued After Margin Expansion Focus
2026-09-22 22:13 · Yahoo
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
2026-09-18 15:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.